Warren Woessner, Shareholder

Phone: 612-373-6900
Email: wwoesner@slwip.com
Website: www.patents4life.com
Professional Biography:
Warren Woessner is a registered patent attorney and a founding shareholder of Schwegman, Lundberg & Woessner. His practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters.
Organization: Schwegman, Lundberg & Woessner, P.A.

Articles in the National Law Review database by Warren Woessner:

CLS Bank v. Alice Corp. (Part 2) Re: Patent Litigation (Posted On Thu, 2013-05-16 21:02)
Supreme Court Decides Bowman v. Monsanto for Monsanto (Posted On Wed, 2013-05-15 19:15)
En (many) Banc(s) Federal Circuit Decides CLS Bank v. Alice Corp. (Posted On Tue, 2013-05-14 20:19)
Allergan V. Sandoz – When Everything “Old” Is “New” Again Re: Patent Law Litigation (Posted On Fri, 2013-05-03 10:02)
Marks & Clerk Releases Life Sciences 2013 Report (Posted On Tue, 2013-04-23 14:05)
Myriad Patent Case Argued Before The Supreme Court – Some Snippets (Posted On Thu, 2013-04-18 03:58)
Approaches to Claiming Diagnostic Methods using Biomarkers in the European Patent Office (EPO) (Posted On Thu, 2013-04-11 05:02)
NOVARTIS A.G. v. UOI – What is Novelty in Indian Courts? (Posted On Tue, 2013-04-09 12:27)
Federal Circuit Will Review Cybor Intellectual Property Decision En Banc (Posted On Tue, 2013-03-19 18:44)
UK National Stem Cell Network Report – The Patent Watch Landscape (Posted On Sat, 2013-03-09 03:10)
Annual Association of University Technology Managers (AUTM) Conference (Posted On Mon, 2013-03-04 14:32)
Deposit of Biological Material – Impact on Validity of Priority Claim (Posted On Sun, 2013-03-03 10:11)
Supreme Court Hears “Replicant Soy Bean” Appeal (Posted On Fri, 2013-02-22 10:01)
Biotech’s Public Relations Problems Continue (Posted On Sun, 2013-02-17 13:04)
USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103 (Posted On Sat, 2013-02-16 02:07)
Time For Myriad To Fight Another Day - DNA Composition (Posted On Tue, 2013-02-05 19:05)
ACLU Files Petitioners’ Brief in AMP v. Myriad Appeal (Posted On Tue, 2013-01-29 08:01)
USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule (Posted On Sun, 2013-01-20 09:10)
PTO Issues Notice on Improvement in Patent Application Quality – A Very Modest Proposal (Posted On Thu, 2013-01-17 17:01)
Supreme Court Denies Cert. in Sherley v. Sebelius (Posted On Wed, 2013-01-09 18:00)
Top Ten Biotech IP Stories of 2012 (Posted On Fri, 2012-12-28 20:07)
In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion (Posted On Fri, 2012-12-21 14:47)
Common Patent for European Union Adopted (Posted On Thu, 2012-12-13 02:11)
Supreme Court Grants Myriad’s Petition for Cert. (Posted On Mon, 2012-12-03 12:40)
USPTO Director Kappos Resigns (Posted On Tue, 2012-11-27 22:10)
Perkinelmer v. Intema – Biomarker Claims Not Patent Eligible (Posted On Sun, 2012-11-25 01:06)
Edwards Lifesciences v. Corevalve – Pig Valve Implants Enabling (Posted On Tue, 2012-11-20 22:05)
Bard v. Gore: Joint Inventors or Just One? (Posted On Fri, 2012-11-16 13:14)
Re-Election of Obama Keeps Patent Law and Policy on Track (Posted On Wed, 2012-11-07 16:02)
Voter Verified Decision Elaborates on Internet Publication (Posted On Tue, 2012-11-06 13:07)
Federal Circuit to Address Computer-Implemented Inventions En Banc (Posted On Thu, 2012-10-11 16:03)
Supreme Court to Review Monsanto v. Bowman (Posted On Mon, 2012-10-08 21:05)
Personalized Medicine Takes Off While Diagnostic Assays are Grounded (Posted On Wed, 2012-09-26 17:02)
Federal Circuit Knocks Outside the Box’s Inequitable Conduct Charges Out of the Box (Posted On Wed, 2012-09-26 12:04)
Akami/McKesson Decision Re-defines Induced Infringement (Posted On Wed, 2012-09-26 05:06)
Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research (Posted On Mon, 2012-09-24 15:02)
1st Media, LLC v. Electronic Arts, Inc. – Specific Intent Means Specific Intent (Posted On Tue, 2012-09-18 03:06)
“Application Denied”- Prometheus In Action (Posted On Mon, 2012-07-30 12:04)
PTO Rules on Pre-issuance Submissions by Third Parties (Posted On Mon, 2012-07-23 11:07)
Why Myriad Should Drop Its Appeal (Posted On Tue, 2012-07-17 12:04)
PTO Guidelines for Process Claims Involving Laws of Nature (Posted On Wed, 2012-07-11 21:05)
“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP (Posted On Wed, 2012-07-11 14:05)
“Obamacare” Survives – Including Path to Generic Biologicals (Posted On Thu, 2012-06-28 12:03)
Lilly Files Amicus Brief in Myriad Remand – With Friends Like This… (Posted On Thu, 2012-06-28 08:47)
Prometheus Unbound – Are Methods Of Medical Treatment The Next “Targets”? (Posted On Thu, 2012-05-24 04:07)
In re Montgomery – “Unbounded” Inherency in Patent Law (Posted On Sat, 2012-05-12 15:21)
USPTO Institutes “QUICK PATH” IDS Pilot Program (Posted On Fri, 2012-05-11 16:07)
Otsuka v. Sandoz – Motivation Trumps Structure (Posted On Wed, 2012-05-09 09:45)
Federal Circuit Orders Briefing in Myriad Remand (Posted On Tue, 2012-05-01 13:48)
Eurand v. Mylan –A “School Of Obviousness" (Posted On Fri, 2012-04-20 17:02)
Supreme Court Reverses In Caraco Appeal (Posted On Tue, 2012-04-17 16:17)
Prometheus Q/A – Which Side Are You On? (Posted On Fri, 2012-04-13 10:24)
U.S. Patent and Trademark Office USPTO Encourages Prosecution After Final – Sort of (Posted On Wed, 2012-04-04 12:07)
Legal Challenge To “ObamaCare” Threatens Generic Biologicals (Posted On Thu, 2012-03-29 13:15)
Handbook of Quality Procedures Before the EPO (Posted On Tue, 2012-03-27 03:28)
Supreme Court Remands In Myriad Appeal (Posted On Mon, 2012-03-26 13:54)
Patent and Trademark Office (PTO) To Biotech Examiners – We’ll Get Back To You! (Posted On Mon, 2012-03-26 10:09)
Indian Patent Office Grants Compulsory License To Bayer Drug (Posted On Wed, 2012-03-21 13:33)
Supreme Court Reverses In Prometheus v. Mayo! (Posted On Tue, 2012-03-20 13:43)
Last Chapter In The “Corn Wars” Or Just The Latest? (Posted On Thu, 2012-03-01 02:22)
Bayer v. Lupin – Patenting The Label Redux (Posted On Tue, 2012-02-28 14:32)
Supreme Court Declines To Review “New And Improved” Written Description Requirement (Posted On Wed, 2012-02-22 18:18)
Supplemental Examination Decision Tree – Lots of Dead Branches? (Posted On Thu, 2012-02-02 01:45)
PTO Proposes Supplemental Examination Rules – Extremely Expensive and Incredibly Complex (Posted On Thu, 2012-01-26 13:40)
AMP Petitions for Cert. and A Look Back (Posted On Thu, 2012-01-19 09:15)
Top 2011 IP Stories on Patents4Life (Posted On Wed, 2012-01-18 14:00)
Prometheus’s Supreme Court Brief – Don’t Confuse Us With “LabCorp” (Posted On Mon, 2011-11-21 14:24)
Powell v. Home Depot – False Petition Not “Egregious Misconduct” (Posted On Wed, 2011-11-16 13:00)
Infringement by Unobvious Changes – A Look (Way) Back (Posted On Tue, 2011-10-18 10:00)
Obviousness = Equivalence? Saint-Gobain v. Siemens (Posted On Mon, 2011-10-17 13:00)
Cordis v. BSC – Therasense at Work (Posted On Mon, 2011-10-03 15:43)
Myriad Petition For Rehearing Denied (Posted On Thu, 2011-09-15 00:04)
Fifty Ways To Leave Your Lover And Nine Ways To Attack Patents (Posted On Tue, 2011-09-13 22:00)
Let The Reformation Begin! Patent Reform Act Passes (Posted On Mon, 2011-09-12 15:00)
Obviousness Objections Based On Combinations Of References – Consistent Warnings From The CAFC (Posted On Wed, 2011-08-31 14:25)
Wegner Paper Probes Myriad Decisions Flaws (Posted On Wed, 2011-08-03 14:14)
AMC v. Myriad – “Laws of Nature” Exception Does Not Include Isolated DNA (Posted On Mon, 2011-08-01 01:08)
Divided Panel Finds DNA Molecules Patentable – Cancer Screening Claims Too Abstract (Posted On Sat, 2011-07-30 02:19)
Patent Office Proposes New Materiality Rules (Posted On Tue, 2011-07-26 04:05)
Inequitable Conduct in Canada – Disarming the “Atomic Bomb” (Posted On Mon, 2011-07-25 13:33)
Judge Michel Takes “Patent Reform” Bills To Task (Posted On Mon, 2011-07-18 10:42)
Boston Scientific Corp. v. Johnson & Johnson: Written Description Requirement Spreads its Wings (Posted On Tue, 2011-07-12 12:16)
Report From Bio International Convention in DC– Everyone In the Patent Pool! (Posted On Fri, 2011-07-01 12:02)
Supreme Court Grants Cert. In Caraco (Posted On Tue, 2011-06-28 14:40)
Supreme Court Grants Cert. In Mayo v. Prometheus (Posted On Thu, 2011-06-23 00:12)
Caraco – The Little Counterclaim That Could? (Posted On Tue, 2011-06-21 12:12)
Supreme Court: Evidence Of Invalidity Must Be “Clear And Convincing” (Posted On Mon, 2011-06-13 09:56)
Nonanalogous Art Lives! In Re Klein (Posted On Fri, 2011-06-10 13:11)
Supreme Court decides Stanford v. Roche – Clarifies Scope of Bayh-Dole Act (Posted On Thu, 2011-06-09 07:32)
Therasense Makes Sense of Inequitable Conduct Defense (Posted On Mon, 2011-05-30 13:46)
Decision of the EPO Enlarged Board of Appeal – Sexual Crossing and Selection of Plants is Not Patentable Even When Using DNA Markers (Posted On Thu, 2011-05-19 02:08)
Patent Office Broadens “First Action Interview” Pilot Program (Posted On Wed, 2011-05-18 13:24)
What Were They Thinking? A Second Look at Lilly v. Sun (Posted On Sun, 2011-05-08 10:45)
Appeals Court Overturns Stem Cell Ban (Posted On Mon, 2011-05-02 13:19)
Patent System Fosters Eugenics – What Next? (Posted On Wed, 2011-04-27 13:48)
Fixing The Holes – Proposed Patent Reform Bill Amendment De-Bugs Grace Period (Posted On Wed, 2011-04-13 14:15)
Myriad Oral Arguments – Section 101 vs. Chemistry 101? (Posted On Wed, 2011-04-13 03:02)
Microsoft V. i4i – Prosecution And The “Variable Proof Regime” (Posted On Mon, 2011-04-04 08:30)
One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe (Posted On Sat, 2011-04-02 09:50)
Banning Stem Cell Research — Or Cloning? Or Both? (Posted On Fri, 2011-04-01 10:29)
Innovation Toys And Analogous Art – Defender Against Hindsight? (Posted On Fri, 2011-03-25 12:13)

Advertisement

Search the National Law Review Database

National Law Review Keyword Search

Warren Woessner, Shareholder

Boost: AJAX core statistics

Advertisement

Upcoming Legal Education Events:

Recent Contributions to the National Law Review

Advertisement

Legal Disclaimer